Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.91B.
ENTERPRISE VALUE (EV)
$3.91B
LivaNova PLC
Market Cap
$4.12B
Enterprise Value (EV)
$3.91B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| LivaNova PLC (LIVN) | $4.12B | $3.91B |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.11B | $4.02B |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | $4.03B |
| ICU Medical, Inc. (ICUI)vs › | $3.99B | $4.97B |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | $4.55B |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | $4.24B |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | $4.36B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | $4.77B |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | $3.64B |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | $4.19B |
Market Cap
$4.12B
Total Debt
$425.00M
Cash
$635.60M
Enterprise Value
$3.91B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
